openPR Logo
Press release

OTC Pediatric Healthcare Market is Anticipated to Reach Close to US$ 10,000 Mn Revenue by 2022 end – Fact.MR’s Report

04-11-2018 09:02 AM CET | Health & Medicine

Press release from: Fact.MR

Fact.MR

Fact.MR

The global market discussion on OTC pediatric healthcare industry can be found in the latest study by Fact.MR, which has been freshly added to its massive collection of research database. The report is titled “OTC Pediatric Healthcare Market Forecast, Trend Analysis & Competition Tracking: Global Review 2017 to 2022”, which works to enlighten the readers about the major factors prompting the growth of the concerned market. Apart from that, the research majorly focuses on OTC pediatric healthcare market’s competitive outlook by profiling major players functioning across the globe. As the report moves ahead, information regarding the prominent trends as well as opportunities in the key geographical segments have also been elaborated, thus enabling companies to be able to make region-specific strategies for gaining competitive lead. Some of the prime regions emphasized in the study include key regions.

Request for Sample Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=257

According to a new study by Fact.MR, the global OTC pediatric healthcare market is projected to witness sluggish growth during 2017-2022. The market is expected to reach nearly US$ 10,000 million value by the end of 2022. Owing to the increased risk associated with OTC pediatric medicines including side-effects and allergic reactions, parents usually prefer medicines prescribed by doctors or pediatrics. Moreover, the U.S. FDA also recommended not to use OTC medicines for children as these medicines may cause life-threatening side-effects. Below are the few insights on the future of OTC pediatric healthcare market.

4 Forecast Highlights on Global OTC Pediatric Healthcare Market

1- Among all the other regions, North America is anticipated to surpass US$ 2,000 million revenue by the end of 2022. Increasing consumer awareness to treat minor health issues among children due to a various initiative by the government such as campaign, awareness drive, etc., is one of the factors driving the growth of OTC drugs in the region.

2- Japan and the Middle East and Africa (MEA) are expected to be the least growing market in OTC pediatric healthcare during 2017-2022.

3- Dermatology OTC pediatric products are anticipated to reach close to US$ 3,500 million towards the end of 2022. Global sales of Dermatology OTC pediatric products is expected to gain around one-third revenue share on the global revenues by the end of 2017.

4- Sales of OTC pediatric products will be highest through drug stores/ pharmacies. By the end of 2017, drug stores/pharmacies are expected to account for nearly one-third of the revenue share of the global revenues. Meanwhile, sales of OTC pediatric products will be the least through convenience stores.

The report has also profiled leading players in the global market for OTC pediatric healthcare, which will remain active through 2022. These include companies such as Johnson & Johnson, Procter & Gamble, Abbott Laboratories, GlaxoSmithKline Plc, Bayer Aktiengesellschaft, Amway Corporation, Church & Dwight Co., Inc., Sanofi, Reckitt Benckiser Group Plc, and Pfizer, Inc.

Browse Full Report with TOC@ https://www.factmr.com/report/257/otc-pediatric-healthcare-market

Table of Contents:

Global OTC Pediatric Healthcare Market – Executive Summary
Global OTC Pediatric Healthcare Market Overview
2.1. Introduction
2.1.1. Global OTC Pediatric Healthcare Market Taxonomy
2.1.2. Global OTC Pediatric Healthcare Market Definition
2.2. Global OTC Pediatric Healthcare Market Size (US$ Mn) and Forecast, 2012-2022
2.2.1. Global OTC Pediatric Healthcare Market Y-o-Y Growth
2.3. Global OTC Pediatric Healthcare Market Dynamics
2.3.1. Drivers
2.3.2. Restraints
2.3.3. Trends
2.4. Supply Chain
2.5. Cost Structure
2.6. Pricing Analysis
2.7. Raw Material Sourcing Strategy and Analysis
2.8. List of Distributors
2.9. Key Participants Market Presence (Intensity Map) By Region
Global OTC Pediatric Healthcare Market Analysis and Forecast By Product Type
3.1. Global OTC Pediatric Healthcare Market Size and Forecast By Product Type, 2012-2022
3.1.1. Gastro Intestinal OTC Pediatric Healthcare Market Size and Forecast, 2012-2022
3.1.1.1. Revenue (US$ Mn) Comparison, By Region
3.1.1.2. Market Share Comparison, By Region
3.1.1.3. Y-o-Y growth Comparison, By Region
3.1.2. Dermatology OTC Pediatric Healthcare Market Size and Forecast, 2012-2022
3.1.2.1. Revenue (US$ Mn) Comparison, By Region
3.1.2.2. Market Share Comparison, By Region
3.1.2.3. Y-o-Y growth Comparison, By Region
3.1.3. ENT OTC Pediatric Healthcare Market Size and Forecast, 2012-2022
3.1.3.1. Revenue (US$ Mn) Comparison, By Region
3.1.3.2. Market Share Comparison, By Region
3.1.3.3. Y-o-Y growth Comparison, By Region
Continued….

Check Discount on this Report@ https://www.factmr.com/connectus/sample?flag=D&rep_id=257

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release OTC Pediatric Healthcare Market is Anticipated to Reach Close to US$ 10,000 Mn Revenue by 2022 end – Fact.MR’s Report here

News-ID: 1010959 • Views:

More Releases from Fact.MR

Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
The latest report on the Bioinformatics Market, projecting robust growth driven by the increasing demand for genomic research, advancements in artificial intelligence (AI), and the rising adoption of precision medicine. Valued at USD 14.29 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 13.4%, reaching USD 50.25 billion by 2034. This significant growth underscores the critical role of bioinformatics in decoding
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Key Players: iRobot Corporation, Neato Robotics, Inc., Yujin Robot, Co., Ltd., and Dyson Inc
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Ke …
Fact.MR today released its latest report on the Residential Robotic Vacuum Cleaner Market, projecting robust growth driven by increasing demand for automation, busy lifestyles, and advancements in smart home technologies. Valued at USD 3.0 billion in 2023, the global market is forecast to expand at a compound annual growth rate (CAGR) of 14.4%, reaching USD 11.6 billion by 2033. This significant growth highlights the rising adoption of robotic vacuum cleaners
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
08-29-2025 | Health & Medicine
Fact.MR
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
The global brain-computer interface (BCI) market was valued at USD 1.6 billion in 2022 and is projected to reach USD 6.5 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2023 to 2033. This expansion reflects the increasing adoption of BCI technologies in medical applications, driven by advancements in neuroscience, AI, and sensor technologies. BCIs enable direct communication between the brain and external devices, offering
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2034 | Key Players: Johnson & Johnson Services Inc; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Takeda Pharmaceutical Company Limited
08-29-2025 | Health & Medicine
Fact.MR
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2 …
The global orally disintegrating tablet (ODT) market is valued at USD 24.45 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.5%, reaching USD 72.68 billion by 2034. This robust growth is driven by the increasing demand for patient-friendly dosage forms, particularly among the elderly, pediatric, and dysphagic populations, who benefit from ODTs' ease of administration without water and rapid dissolution. ODTs enhance

All 5 Releases


More Releases for OTC

Lawsuit filed for Investors who lost money with shares of adidas AG (OTC: ADDYY, …
An investor, who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), filed a lawsuit over alleged violations of Federal Securities Laws by adidas AG in connection with certain allegedly false and misleading statements. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and for certain investors are short and strict deadlines running. Deadline: June 27, 2023. adidas AG (OTC: ADDYY, OTC: ADDDF) investors should contact
Investigation for Investors in adidas AG (OTC: ADDYY, OTC: ADDDF) announced over …
An investigation on behalf of investors in shares of adidas AG (OTC: ADDYY, OTC: ADDDF) was announced over potential breaches of fiduciary duties by certain officers and directors at adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain adidas AG officers and
AMERICAN HEMP VENTURES INC (OTC: AMHV) TO BECOME YOUNEEQAI TECHNICAL SERVICES In …
FOR IMMEDIATE RELEASE Denver Colorado, March 31, 2023, American Hemp Ventures, Inc. (OTC: AMHV) announced today that its name has changed effective immediately to YouneeqAI Technical Services inc. (OTC: YQAI) reflecting the Company's new focus into cookie-less AI technology services. The current management team has over 50 years of experience in technology services and innovation. Murray Galbraith, YQAI's CEO, is the Founder of YouneeqAI's software solution and has operated several private technology
Investigation announced for Investors who lost money with shares of adidas AG (O …
An investigation was announced for investors of adidas AG (OTC: ADDYY, OTC: ADDDF) shares over potential securities laws violations by adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of adidas AG (OTC: ADDYY,
Fuel Cell Market Technological Trends and Business Opportunities 2021 To 2026; P …
MarketInsightsReports has published a report titled global Fuel Cell Market research report 2021 that is a detailed observation of several aspects, including the rate of growth, technological advances, and different methodologies implemented by the primary current market players. The report is based on a collective analysis of data, which is obtained through primary and secondary research. It provides a systematic approach to the current and prospective scenario of this market. The
Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF). Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to